L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity

Clinical Trial

Study Details

Enrollment

50

Interventions

Description

L-Arginine 1000 mg free form, rapid release capsules

Name

L-Arginine

Type

Drug

Phase

Phase 3

Status

COMPLETED

Study ID #

NCT05470998

Study Type

Interventional

Summary

This study aims to investigate the possible efficacy and safety of L-Arginine in children having Sickle Cell Disease with increased Tricuspid Regurgitant Jet Velocity

Study Overview

Conditions

Sickle Cell Disease

Contacts and Locations

Locations

Facility

Tanta university
Tanta
Other (Non U.s.)
Egypt

GeoPoint

30.78847, 31.00192